We have located links that may give you full text access.
Salt-Free Reduction of Transition Metal Complexes by Bis(trimethylsilyl)cyclohexadiene, -dihydropyrazine, and -4,4'-bipyridinylidene Derivatives.
Accounts of Chemical Research 2019 Februrary 23
Chemical reduction of transition metals provides the corresponding low-valent transition metal species as a key step for generating catalytically active species in metal-assisted organic transformations and is a fundamental unit reaction for preparing organometallic complexes. A variety of metal-based reductants, such as metal powders and organometallic reagents of alkali and alkaline-earth metals, have been developed to date to access low-valent metal species. During the reduction, however, reductant-derived metal salts are formed as reaction waste, some of which often interact with the reactive low-valent metal center, thereby disrupting the catalytic performance and hampering the isolation of organometallic complexes as a result of salt coordination to the coordinatively unsaturated vacant and active sites and the formation of thermally unstable ate complexes. In this Account, we emphasize the synthetic utility and versatility of organic reductants containing two trimethylsilyl groups, i.e., 1,4-bis(trimethylsilyl)cyclohexa-2,5-diene (1a) and its methyl derivative (1b), 1,4-bis(trimethylsilyl)dihydropyrazine (2a) and its dimethyl (2b) and tetramethyl (2c) derivatives, and 1,1'-bis(trimethylsilyl)-4,4'-bipyridinylidene (3), leading to the reduction of various kinds of metal compounds in a salt-free fashion by release of two electrons together with the coproduction of easily removable (hetero)aromatics and trimethylsilyl derivatives from these organic reductants 1-3. When homoleptic chlorides of group 5 and 6 metals are treated with 1a and 1b, in situ-generated highly reactive low-valent metal species react with redox-active molecules such as ethylene, α-diimines, and α-diketones to produce metallacyclopentane, (ene-diamido)metal, and (ene-diolato)metal complexes, respectively. The advantage of the salt-free protocol is further exemplified in the low-valent titanocene-catalyzed Reformatsky-type reaction when 2c is used as a reductant: the yield of the product using the organosilicon reductant is higher than that when manganese powder is used as the reductant for the catalytic Reformatsky-type reaction of ethyl 2-bromoisobutyrate and its derivatives with various aldehydes. Moreover, when halides, carboxylates, and acetylacetonate compounds of late transition metals and main-group elements are treated with the organosilicon reductant 2c, metal(0) particles are smoothly precipitated under mild conditions. Among them, metallic nickel(0) nanoparticles are applicable to reductive biaryl formation and reductive cross-coupling of aryl halides/aryl aldehydes. In addition, reduction of the heterogeneous catalysts on a solid supporting matrix was also achieved by this salt-free reduction method; volatile byproducts are easily removed from the catalyst surface without suppressing the catalytic performance. Thus, the salt-free reduction strategy is a very powerful synthetic method that can be extended to various metals throughout the periodic table.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app